Literature DB >> 35819758

Generation of Endogenously Tagged Membrane Trafficking Regulators Using CRISPR Genome Editing.

Syed Mukhtar Ahmed1.   

Abstract

Vesicle trafficking entails packaging and transport of membrane-associated proteins to their target membranes, and recycling or degradation of endocytosed proteins. Biochemical and cell biological studies of vesicle trafficking often require the introduction of epitope tags or fluorescent protein markers for protein purification and tracking in cells. Previously, such tagging experiments in mammalian cells mainly used overexpression systems, which could lead to artifacts. Abnormally high expression levels also prevent us from studying individual vesicle trafficking events with precision. With the advent of CRISPR technologies, epitope tags and fluorescent proteins can now be introduced into endogenous proteins in almost any cell type that are proliferating in culture. This chapter describes approaches for inserting tags at the endogenous loci of genes, with the vesicle tethering protein complex, exocyst, as an example.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CRISPR-Cas9; Endogenous tagging; Exocyst; Gene editing; Membrane trafficking; Tethering complex; Vesicle transport

Mesh:

Substances:

Year:  2022        PMID: 35819758     DOI: 10.1007/978-1-0716-2209-4_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  A PCR-based strategy to generate yeast strains expressing endogenous levels of amino-terminal epitope-tagged proteins.

Authors:  Keith R Booher; Peter Kaiser
Journal:  Biotechnol J       Date:  2008-04       Impact factor: 4.677

2.  Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity.

Authors:  Tanya Vavouri; Jennifer I Semple; Rosa Garcia-Verdugo; Ben Lehner
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

Review 3.  Single-Molecule Studies in Live Cells.

Authors:  Ji Yu
Journal:  Annu Rev Phys Chem       Date:  2016-04-08       Impact factor: 12.703

4.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

5.  Rapid and efficient clathrin-mediated endocytosis revealed in genome-edited mammalian cells.

Authors:  Jeffrey B Doyon; Bryan Zeitler; Jackie Cheng; Aaron T Cheng; Jennifer M Cherone; Yolanda Santiago; Andrew H Lee; Thuy D Vo; Yannick Doyon; Jeffrey C Miller; David E Paschon; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; David G Drubin
Journal:  Nat Cell Biol       Date:  2011-02-06       Impact factor: 28.824

6.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.

Authors:  Elitza Deltcheva; Krzysztof Chylinski; Cynthia M Sharma; Karine Gonzales; Yanjie Chao; Zaid A Pirzada; Maria R Eckert; Jörg Vogel; Emmanuelle Charpentier
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

7.  Exocyst dynamics during vesicle tethering and fusion.

Authors:  Syed Mukhtar Ahmed; Hisayo Nishida-Fukuda; Yuchong Li; W Hayes McDonald; Claudiu C Gradinaru; Ian G Macara
Journal:  Nat Commun       Date:  2018-12-03       Impact factor: 14.919

8.  Efficient labeling and imaging of protein-coding genes in living cells using CRISPR-Tag.

Authors:  Baohui Chen; Wei Zou; Haiyue Xu; Ying Liang; Bo Huang
Journal:  Nat Commun       Date:  2018-11-29       Impact factor: 14.919

9.  Live-cell imaging of exocyst links its spatiotemporal dynamics to various stages of vesicle fusion.

Authors:  Felix Rivera-Molina; Derek Toomre
Journal:  J Cell Biol       Date:  2013-05-20       Impact factor: 10.539

10.  The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.

Authors:  Krzysztof Chylinski; Anaïs Le Rhun; Emmanuelle Charpentier
Journal:  RNA Biol       Date:  2013-04-05       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.